# Post Covid

शीर्ष पॉडकास्ट एपिसोड
अपडेट किया गया:

Ed Seguine CEO of Clinical Ink Talks About Hybrid Clinical Trials During and Post COVID-19

Ed Seguine, CEO of Clinical Ink, talks about how hybrid trials, BYOD ePRO, and DDC can provide a valuable solution during a healthcare crisis like COVID-19 You can learn more about Ed Seguine and Clinical Ink below: https://www.clinicalink.com/virtual-trials/  

The World Pre and Post COVID-19

Liam and Eric join us in the studio to discuss the future of the world we live in and how we think it'll be different after the COVID-19 Pandemic. --- Support this podcast: https://podcasters.spotify.com/pod/show/ponderosaponderors/support

Finding the New Normal

Post COVID-19, we are all hoping for things to go back to normal. That’s not going to happen. We are going to have to find a “New Normal.

A strategy for SMEs Post Covid-19

Discussing potential options for SMEs during and after COVID-19

Girls in STEM in the 90s

She's back!!! Post Covid, Spears sisters, and nostalgic 90s STEM games for girls... Unhinged chatting with Jennie and catch yo'self a quick LOL. (heyMAMAheypodcast on Instagram) --- Send in a voice message: https://anchor.fm/jennie-giachelli/message

Q&A: Lilly "Insulin Value Program" Sets Price At $35 Monthly

Lilly Diabetes announced this morning it would cut the price of its insulin to $35. What does this really mean? How long will it last? Why are those with government insurance left out? Stacey asks your questions and gets answers from Lilly's US Insulin Brand Leader, Andy Vicari. Here's the Full L…

Residential Opportunities During and Post COVID-19

We all know that an increase in wealth is something that typically takes place during a recession. With that being said we are in a Global Pandemic. Are there still opportunities available for others to capitalize? In this episode we discuss the opportunities available for Residential Real Estate I…

Genentech’s Erica Taylor on how healthcare brands became mainstream post-Covid

Genentech VP, CMO Erica Taylor joins The Current Podcast to share her unique journey from immunology to biotech marketing, and the evolving role of biotech brands in mainstream media.    Episode Transcript Please note, this transcript  may contain minor inconsistencies compared to the episode audio…